Since mid-2022, the macro acquisition environment has faced the challenges of inflation and increasing interest rates, among a variety of other headwinds. Global deal flow is down from its 2021 peak. Yet, as this white paper...more
The next in our series of posts sharing key takeaways from panels at the Healthcare & Life Sciences Private Equity and Lending Conference is authored by our colleagues Trey Andrews and Jeff Alberg....more
It’s becoming very clear that the private equity industry and other investors are positioning themselves to take advantage of the United States’ generational tsunami by investing in the home health and hospice sectors....more